The Rx Research Corner is a blog written by the Research Team at PCMA. This blog will take a closer look at complex data and new research findings. Topics cover the PBM and prescription drug space and range from pricing, to policies, and to patient issues such as access and equity.
There are More Independent Pharmacies, Just Look at Real, Accurate Data
Using a gold-standard pharmacy dataset from the National Council for Prescription Drug Programs (NCPDP) and a transparent methodology, PCMA produces credible research with a clear conclusion: there are more independent pharmacies now than any time over the last decade.
Mandating Pharmacy Reimbursement Will Increase Prescription Drug Spending
Paying pharmacies more for dispensing medications will raise prescription drug costs without improving value.
Biosimilars Versus Biologics – How About Both?
Biosimilars play an important role in lowering net costs.
The Upside of More Drugs: How Competition Among Brand-Name Drugs Works for Patients
PBMs leverage competition between drugs to create savings for patients.
“Patent Thickets” are Anti-Competitive and Lead to Higher Drug Costs
Patent thickets are a drug manufacturer’s strategy that keeps competitor products off the market and reduces PBMs’ ability to negotiate savings.
Clearing the Air: World Asthma Day
May is Asthma Awareness Month, and today – May 5 – is World Asthma Day. The Asthma and Allergy Foundation of America is marking the day with the release of their 2021 Asthma Capitals Report.
